4.8 Article

Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency

期刊

CELL
卷 133, 期 2, 页码 250-264

出版社

CELL PRESS
DOI: 10.1016/j.cell.2008.03.028

关键词

-

资金

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NCI NIH HHS [R37 CA084198, R37 CA084198-08, 5-R37-CA084198, 5-R01-CA087869, R01 CA087869] Funding Source: Medline
  3. NICHD NIH HHS [R01 HD045022, R01 HD045022-05] Funding Source: Medline
  4. NIGMS NIH HHS [T32 GM007753] Funding Source: Medline
  5. PHS HHS [5-R01-HDO45022] Funding Source: Medline

向作者/读者索取更多资源

Pluripotent cells can be derived from fibroblasts by ectopic expression of defined transcription factors. A fundamental unresolved question is whether terminally differentiated cells can be reprogrammed to pluripotency. We utilized transgenic and inducible expression of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) to reprogram mouse B lymphocytes. These factors were sufficient to convert nonterminally differentiated B cells to a pluripotent state. However, reprogramming of mature B cells required additional interruption with the transcriptional state maintaining B cell identity by either ectopic expression of the myeloid transcription factor CCAAT/enhancer-binding-protein-alpha (C/EBP alpha) or specific knockdown of the B cell transcription factor Pax5. Multiple iPS lines were clonally derived from both nonfully and fully differentiated B lymphocytes, which gave rise to adult chimeras with germline contribution, and to late-term embryos when injected into tetraploid blastocysts. Our study provides definite proof for the direct nuclear reprogramming of terminally differentiated adult cells to pluripotency.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据